540729-BOM

Vanta Bioscience Ltd.

BSE: 540729

SME

Sector: Healthcare

Industry Group: Healthcare Services

Industry: Healthcare Research, Analytics & Technology

25.29+0.0 (+0.00%)

13 Jul, 12:00 AM

Overview

Analysis Statements Technicals Forecast Peers Resources News

Stock Scores

Quality Score

Score not available

Value Score

Score not available

Price Momentum Score

Score not available

QVM Score

Score not available

Key Metrics

Market Cap

17.99

P/E (TTM)

-222.33

P/B

0.85

P/S (TTM)

9.90

EV/EBITDA

182.56

CAPE (5Y)

ROE (TTM)

-0.51

ROCE (TTM)

-13.03

ROA (TTM)

-0.11

Avg 3Y ROE

-17.31

Earnings 3Y CAGR

Sales 3Y CAGR

-33.85

Sales 5Y CAGR

-28.96

Debt/Equity

1.80

Consensus TP

Strong Buy %

Promoter Holding

72.81

Pledged %

0.00

Stock Analysis

Fundamental analysis overview of Vanta Bioscience Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.

Views

Red Flags

Positive

Stock is cheap and PE TTM is at a discount to industry median

PE TTM of -222.33 indicates that the stock is cheap on a standalone basis. Discount to industry median P/E is decent at -827.04%

What is P/E Ratio?

Median: 30.58

Value -222.33

-222.33134.88

Reasonable Debt to Equity, and decreasing

The company has reasonable Debt to Equity of 1.8 as on 31 Mar 2026 but Debt to Equity decreased by 4.92 in the last 1 year

What is Debt to Equity?

Consistently pays dividend

The company has not missed dividend payments once in the last 10 financial years

What is Dividend streak?

Negative

Low revenue growth and lower than median growth of industry

The company delivered moderate revenue growth of -7.49% for 12-month ended 31 Mar 2026 and the growth was 14.38 percentage points lower than median growth of industry

What is Sales growth (1Y)?

Median: 6.89

Value -7.49

-32.8631.37

Low dividend yield

The company has a low dividend yield of 0.0%

What is Dividend yield?

Neutral

Low ROE but improving trend

The company reported low ROE of -0.51% for 12-month ended 31 Mar 2026 but ROE improved by 3675 bps from 1 year ago

What is ROE (FY)?

Financial Snapshot

See detailed analysis

Multi-year trends for Vanta Bioscience Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.

Net Revenue FY

Profit After Tax FY

ROE FY

EBITDA FY

Vanta Bioscience Ltd. Shareholding Pattern

Quarterly breakdown of Vanta Bioscience Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.

	Mar 2017	Sep 2017	Mar 2018	Sep 2018	Mar 2019	Sep 2019	Mar 2020	Sep 2020	Mar 2021	Sep 2021	Mar 2022	Sep 2022	Mar 2023	Sep 2023	Mar 2024	Sep 2024	Mar 2025	Jun 2025	Sep 2025	Mar 2026
Total Promoter	98.43	72.45	72.45	72.45	69.93	69.93	69.93	69.93	69.11	69.00	69.00	69.36	69.36	69.36	69.36	69.36	69.36	72.81	72.81	72.81
Indian Promoter	98.43	72.45	72.45	72.45	69.93	69.93	69.93	69.93	69.11	69.00	69.00	69.36	69.36	69.36	69.36	69.36	69.36	72.81	72.81	72.81
Foreign Promoter	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Institutions	0.00	-	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mutual Funds / UTI	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FI/Bank/Insurance	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Govt	0.00	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
FII	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Institutions	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Non-Institution	1.57	27.55	27.55	27.55	30.07	30.07	30.07	30.07	30.89	31.00	31.00	30.64	30.64	30.64	30.64	30.64	30.64	27.19	27.19	27.19
Bodies Corporate	0.00	-	2.36	0.58	1.07	1.12	1.11	1.11	1.06	0.91	1.11	0.80	0.80	0.76	0.94	0.88	0.89	0.79	0.42	0.42
Others (incl. Retail) No. of shareholders	1.57 0	27.55 240	25.19 246	26.97 218	29.00 245	28.95 254	28.96 260	28.96 305	29.83 340	30.09 392	29.89 387	29.84 373	29.84 374	29.88 368	29.70 399	29.76 406	29.75 391	26.40 391	26.77 405	26.77 412

Bulk, Block and Insider Trades

Recent bulk deals, block deals, and insider trading activity in Vanta Bioscience Ltd. shares as reported to NSE and BSE.

No bulk, block or insider trade data available.

No corporate action data available.

Company Profile

Overview of Vanta Bioscience Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.

Vanta Bioscience Limited is an India-based preclinical contract research company. The Company provides services for testing and contract research in the fields of clinical research, pre-clinical research, biopharma services, analytical testing and research, and environmental studies. It offers a hos...

Key personnel

Mr. Annabatula Kiran Kumar

Chief Financial Officer

Mr. Sadhanala Venkata RaoD

Chief Executive Officer, Whole Time Director

Mr. Dopesh Raja MulakalaD

Managing Director, Director

Dr. Padmanabhuni Venkata AppajiD

Independent Director

Dr. Yogeswara Rao DandaD

Independent Director

Dr. Kathyayani GonuguntlaD

Independent Director

Dr. Kathyayani GonuguntlaD

Independent Director

Incorporated on

29 Apr 2016

Last Annual

31 Mar 2026

Last Interim

31 Mar 2026

No. of Employees

IPO date

06 Oct 2017

Free Float

19,34,000

Website

https://www.vantabio.com/

Phone no.

+914066575454

Address

NO. 02/G/308/G, NO. 3/FF/SF/1-20-248 UMAJAY COMPLEX, RASOOLPURA, SECUNDERABAD, , 500003, India

Frequently Asked Questions

What is the current share price of Vanta Bioscience Ltd.?

The current share price of Vanta Bioscience Ltd. is ₹ 25.29 as of 13 Jul 2026.

What is the market capitalisation of Vanta Bioscience Ltd.?

The market capitalisation of Vanta Bioscience Ltd. stands at ₹ 17.99 Cr.

What is the PE ratio of Vanta Bioscience Ltd.?

The Price-to-Earnings (PE) ratio of Vanta Bioscience Ltd. is -222.33 as of the latest trailing twelve months data.

What is the ROE and ROCE of Vanta Bioscience Ltd.?

Vanta Bioscience Ltd. has a Return on Equity (ROE) of -0.51% and a Return on Capital Employed (ROCE) of -13.03% as per the latest financial reports.

What is the 52-week high and low of Vanta Bioscience Ltd.?

The 52-week high of Vanta Bioscience Ltd. is - and the 52-week low is -.

What is the dividend yield of Vanta Bioscience Ltd.?

The dividend yield of Vanta Bioscience Ltd. is 0.00% based on the current market price.

What is the FII and DII holding in Vanta Bioscience Ltd.?

Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 26.77% of Vanta Bioscience Ltd. shares.

What sector does Vanta Bioscience Ltd. belong to?

Vanta Bioscience Ltd. operates in the Healthcare sector.

What is the beta of Vanta Bioscience Ltd.?

The beta of Vanta Bioscience Ltd. is 0.70, indicating its price volatility relative to the broader market.

What is the RSI of Vanta Bioscience Ltd.?

The 14-day Relative Strength Index (RSI) of Vanta Bioscience Ltd. is 62.57, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.

Vanta Bioscience Ltd.

Stock Scores

Key Metrics

Share Price

Stock Analysis

Financial Snapshot

Vanta Bioscience Ltd. Shareholding Pattern

Bulk, Block and Insider Trades

Company Profile

Frequently Asked Questions

Stock Analysis

Company Profile